he has been stated Q1 in a pm. and that was screen shot

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

CSX's Leadership in Transportation Conference CSX Corp. Executive Vice President and Chief Financial Officer, Sean Pelkey, is set to engage with key industry stakeholders at the upcoming UBS Global Industrials and Transportation Conference. This important event is scheduled to take place on a Wednesday morning, a date that promises significant opportunities for insights...

Understanding Dividend Income from Kohl's Stock Kohl’s Corporation (NYSE: KSS) is preparing to share its fourth-quarter financial results. Investors and analysts alike are keenly anticipating this release. What Are Analysts Expecting? Analysts have forecasted a decrease in earnings, projecting the company to report earnings of 77 cents per share, a decline from $1.67...

Introduction of Bela Bajaria to Coca-Cola's Board The Coca-Cola Company recently welcomed Bela Bajaria, the Chief Content Officer of Netflix, to its Board of Directors, reflecting a significant strategic move. The election emphasizes Coca-Cola’s commitment to integrating diverse perspectives into its leadership. The Experience of Bela Bajaria Bela Bajaria’s...

Eric Schwartz Takes the Helm at Loeb Seasoned Leader to Drive Innovation, Growth, and Team-First Culture Loeb has announced an exciting new chapter in its journey as Eric Schwartz has been appointed President. In this pivotal role, Schwartz will steer the company's strategic direction, embracing its long-standing tradition of innovation and aiming for growth across...

Join the Class Action Lawsuit Against Bumble Inc. Attention, Bumble Inc. investors! If you've experienced significant losses in your investments, you may be entitled to participate in a class action lawsuit initiated by the well-established law firm, Bronstein, Gewirtz & Grossman, LLC. This lawsuit addresses the grievances of shareholders who acquired Bumble securities...